Event-free survival after (68) Ga-PSMA-11 PET/CT in recurrent hormone-sensitive prostate cancer (HSPC) patients eligible for salvage therapy

BACKGROUND/AIM: Prostate-specific-membrane-antigen/positron emission tomography (PSMA-PET) detects with high accuracy disease-recurrence, leading to changes in the management of biochemically-recurrent (BCR) prostate cancer (PCa). However, data regarding the oncological outcomes of patients who perf...

Descripción completa

Detalles Bibliográficos
Autores principales: Ceci, Francesco, Rovera, Guido, Iorio, Giuseppe Carlo, Guarneri, Alessia, Chiofalo, Valeria, Passera, Roberto, Oderda, Marco, Dall’Armellina, Sara, Liberini, Virginia, Grimaldi, Serena, Bellò, Marilena, Gontero, Paolo, Ricardi, Umberto, Deandreis, Désirée
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250462/
https://www.ncbi.nlm.nih.gov/pubmed/35217883
http://dx.doi.org/10.1007/s00259-022-05741-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250462/
https://www.ncbi.nlm.nih.gov/pubmed/35217883
http://dx.doi.org/10.1007/s00259-022-05741-9

Ejemplares similares